GelStat (GSAC) Stock Price & Analysis
GSAC Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- N/A
- Previous Close
- $0.01
- Volume
- 7,824
- Average Volume (3M)
- 85.56K
- Market Cap
- $1.12M
- Enterprise Value
- $963.59B
- Total Cash (Recent Filing)
- $71.41K
- Total Debt (Recent Filing)
- $849.62K
- Price to Earnings (P/E)
- ―
- Beta
- 1.23
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
GSAC FAQ
What is GelStat’s market cap?
When is GelStat’s upcoming earnings report date?
Is GelStat overvalued?
Does GelStat pay dividends?
What is GelStat’s EPS estimate?
How many shares outstanding does GelStat have?
Which hedge fund is a major shareholder of GelStat?
What is the TipRanks Smart Score and how is it calculated?
Company Description
GelStat
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
- Sector
- Technology
- Industry
- Medical - Pharmaceuticals
- CEO
- Javier G. Acosta
- Employees
- 2
- Website
- www.gelstat.com
- Address
- 3557 SW Corporate Parkway, Palm City, FL, 34990, US



